News tagged with oncology drugs
Biologically targeted nanoparticles may boost radiation therapy effects
(PhysOrg.com) -- Making a tumor more sensitive to radiotherapy is a primary goal of combining chemo and radiation therapy to treat many types of cancer, but with the chemotherapy drugs come unwanted side effects.
Nanotechnology / Bio & Medicine
Oct 27, 2011 |
not rated yet |
0
|
Studies find new drugs boost skin cancer survival
(AP) -- They're not cures, but two novel drugs produced unprecedented gains in survival in separate studies of people with melanoma, the deadliest form of skin cancer, doctors reported Sunday.
Jun 06, 2011 |
not rated yet |
0
Estrogen blocker cuts breast cancer risk 65%: study
An anti-estrogen drug has shown a "promising" 65-percent reduction of breast cancer risk among post-menopausal women, according to the findings of a study released Saturday.
Jun 04, 2011 |
not rated yet |
0
Research suggests link between infertility, low egg reserve, and breast/ovarian cancer gene (BRCA1)
A New York Medical College physician who specializes in restoring or preserving fertility in female cancer patients has discovered a possible link between the presence of breast cancer genes and infertility.
Dec 18, 2009 |
not rated yet |
0
Study first to evaluate prevalence, impact of off label chemotherapy in breast cancer
At some point during their care, more than one-third of metastatic breast cancer patients receive chemotherapy off label, the legal use of FDA-approved drugs in a different indication than for which they were ...
May 15, 2009 |
not rated yet |
0
New chemo regimen helps children with neuroblastoma
A new high-dose chemotherapy regimen has been shown to improve survival of children with high-risk neuroblastoma, a common pediatric cancer, according to a European clinical trial published Sunday.
Jun 06, 2011 |
not rated yet |
1
Patient access schemes for high-cost cancer medicines: Good in theory, difficult in practice
created by the pharmaceutical industry to allow access to expensive cancer drugs—can be fraught with administrative problems, meaning that money does not reach the parts of the UK National Health Service that it should, ...
Jan 31, 2010 |
5 / 5 (1) |
0
Low forms of cyclin E reduce breast cancer drug's effectiveness
Overexpression of low-molecular-weight (LMW-E) forms of the protein cyclin E renders the aromatase inhibitor letrozole ineffective among women with estrogen-receptor-positive (ER+) breast cancers, researchers from The University ...
Feb 09, 2010 |
not rated yet |
0
New cancer study takes major step toward improved treatment
Cancer researchers at the University of Oklahoma Health Sciences Center have found a way to turn ineffective new cancer drugs into cancer-fighters. By using their patented chemical compound, SHetA2, researchers tricked cancer ...
Dec 01, 2009 |
5 / 5 (2) |
0
Less Toxic Drug Prolongs Survival in Metastatic Breast Cancer
(PhysOrg.com) -- Research from the Northwestern University Feinberg School of Medicine has found that a less toxic, solvent-free chemotherapy drug more effectively prevents the progression of metastatic breast cancer and ...
May 26, 2009 |
not rated yet |
1
MU College of Veterinary Medicine to study efficacy of cancer drug in dogs
A cancer drug that benefits people may soon benefit man's best friend.
Oct 05, 2010 |
not rated yet |
0
Lung cancer survival rates improved through use of individualized chemotherapy
Chemotherapy is the best broad defense against cancer recurrence after surgical resection. However, it is difficult to predict which patients will benefit from which regimen of anticancer drugs, if at all. Building on existing ...
Sep 01, 2010 |
not rated yet |
0
Review and approval of oncology and hematology drugs at FDA from 2005 to 2007
Over a two and half year period, beginning in 2005 when the U.S. Food and Drug Administration's oncology drug product's office began reviewing marketing applications, a total of 60 new oncology and hematology drugs were reviewed, ...
Medicine & Health / Medications
Jan 29, 2010 |
not rated yet |
0
Pioneering French oncologist Mathe dies at 88
(AP) -- Oncologist Georges Mathe, who in 1959 performed the world's first bone marrow transplant, has died, the French president's office said Monday. He was 88.
Oct 18, 2010 |
not rated yet |
0
Aromatase inhibitors increased risk of heart disease in postmenopausal women with breast cancer
Postmenopausal women who take aromatase inhibitors as a treatment for breast cancer may be at an increased risk for developing cardiovascular disease, according to the results of a meta-analysis.
Dec 09, 2010 |
not rated yet |
0
